MedTrace Logo

Check and Support -Enhancing the Treatment of Hypertension in Outpatient Care, a Multicenter Study

NCT02377960 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2018-07-11

No results posted yet for this study

Summary

The purpose of this pragmatic multi-centre, cluster randomized controlled trial is to test the effectiveness of tailored SMS-text message support combined with an information-motivation-behavioral skills (IMB) model-based initiation of medication in helping outpatient care patients with hypertension to achieve blood pressure target and to enhance medication adherence.

Conditions

  • Hypertension
  • Blood Pressure
  • Patient Compliance
  • Patient Adherence
  • Medication Adherence

Interventions

BEHAVIORAL

IMB model-based initiation of antihypertensive medication

1.An IMB model-based initiation of medication i.e. a nine-point check list to be fulfilled by physician and patient together when ordering the antihypertensive medication for the first time

BEHAVIORAL

Tailored SMS-text message support

2.Tailored SMS-text message support for the first 12 months of medication. At the beginning (2 weeks), text messages are send on daily basis and focused on medications-reminders and coping with potential side-effects of medication. After that, text messages will be sent less often and the focus will change to keeping up with medication and reminding of importance of performing adequate home BP self-monitoring, achieving the BP target and attending clinical appointments.

BEHAVIORAL

Usual care

Usual care

Sponsors & Collaborators

  • Health Centre of Jyväskylä Cooperation Area

    collaborator UNKNOWN

  • Central Finland Hospital District

    collaborator OTHER

  • Occupational Health Care Työterveys Aalto

    collaborator UNKNOWN

  • Mehiläinen Jyväskylä Occupational health services

    collaborator UNKNOWN

  • Northern Savo Hospital District

    collaborator OTHER

  • Kuopio University Hospital

    lead OTHER

Principal Investigators

  • Pekka Mäntyselkä, MD,Prof. · University of Eastern Finland

  • Aapo Tahkola, LM,PHD st. · Health Centre of Jyväskylä Cooperation Area

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-27
Primary Completion
2018-03-06
Completion
2018-03-06

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02377960 on ClinicalTrials.gov